Comparative effectiveness of aspirin dosing in cardiovascular disease and diabetes mellitus: a subgroup analysis of the adaptable trial
Narcisse DI, Kim H, Wruck LM, et al.
Diabetes Care. 2023;dc230749.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Incidence of diabetes among youth before and during the Covid-19 pandemic
Mefford MT, Wei R, Lustigova E, et al.
JAMA Netw Open. 2023;6(9):e2334953.
Leggi
Historical insights and current perspectives on the diagnosis and management of pre-symptomatic type 1 diabetes
Simmons K, Frohnert B, O’Donnell H, et al.
Diabetes Technol Ther. Pub. online 11 Sep 2023.
Leggi
Differential evolution of diabetic ketoacidosis in adults with pre-existent versus newly diagnosed type 1 and type 2 diabetes mellitus
Ata F, Khan AA, Khamees I, et al.
BMC Endocr Disord. 2023;23(1):193.
Leggi
Empagliflozin normalizes fasting hyperglycemia and improves postprandial glucose tolerance in totally pancreatectomized patients: a randomized, double-blind, placebo-controlled crossover study
Baekdal M, Nielsen SW, Hansen CP, et al.
Diabetes Care. 2023;dc230645.
Leggi
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation
Kaptoge S, Seshasai SRK, Su L, et al.
The Lancet Diabetes and Endocrinology. Pub. online 11 Sep 2023.
Leggi
Efficacy and safety of once‐weekly versus once‐daily basal insulin analogues in the treatment of type 2 diabetes mellitus: A systematic review and meta‐analysis
Karakasis P, Patoulias D, Pamporis K, et al.
Diabetes Obes Metab. Pub. online 5 Sep 2023.
Leggi
Expected basal insulin requirement during CSII therapy by age group, sex and BMI, based on 25,718 young people with type 1 diabetes in the DPV registry
Biester T, Eckert A, Becker M, et al.
Diabetes Technol Ther. Pub. online 5 Sep 2023.
Leggi
Comparison of glycemic risk index (GRI) with time in range for assessing glycemic quality
Kim JY, Yoo JH, Kim JH
Diabetes Technol Ther. Pub. online 5 Sep 2023.
Leggi
Dapagliflozin improves erectile dysfunction in patients with type 2 diabetes mellitus: an open‐label, non‐randomized pilot study
Cannarella R, Condorelli RA, Leanza C, et al.
Diabet Med. 2023;e15217.
Leggi